Director Stuart M McGuigan purchases 15,000 shares of Enhabit (EHAB) for $132.2K; holdings up 47.2% to 46.8K shares
Director McGuigan acquired 15,000 shares at $8.81 on 2024-12-10, increasing his position by 47.2% to 46.8K total shares worth $132,150. The purchase occurred near the company's 52-week midpoint ($6.89–$11.65 range), at a price 26.8% below the 52-week high. Enhabit reported a net loss of $110.2M on quarterly revenue of $253.6M, with full-year revenue declining 2.3% year-over-year; the company remains unprofitable. The director's accumulation into a loss-making healthcare provider at a depressed valuation point, combined with increasing holdings during operational distress, presents a substantive transaction warranting monitoring of underlying operational trends and the director's conviction thesis.